Authors


Patricia Weiser, Pharm.D.

Latest:

FDA Advisory Committee Supports New Surrogate Endpoint To Assess Multiple Myeloma Treatments

This decision may lead to faster approval of new treatments for multiple myeloma.


Al Fasola

Latest:

The Well-being Measurement Problem

Surveys are important, but respondents may hide their true thoughts and feelings.


Adam E. Block, Ph.D.

Latest:

Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates

Amid struggling providers, furloughs of essential workers, years of premium increases and record high earnings, for-profit health plans should consider options for directly helping their networks.


Scott Palmer

Latest:

Key Takeaways for Managed Care Organizations as No Surprises Act Goes Into Effect

The No Surprises Act is scheduled to go into effect in January. The law will require providers to provide patients with details of the new balance billing requirements, any state-level limitations or prohibitions in the state of service, and the dispute resolution process.


Hannah Clarke

Latest:

Potential Urology Drug Savings Through Mark Cuban Drug Company

The greatest savings are seen for 90-tablet prescriptions.


Mike Szczesny

Latest:

Transforming Healthcare Workforce for Future Challenges

Discover how healthcare is evolving, the workforce hurdles it faces, and the game-changing role of technology in overcoming these obstacles.




Curtis Sherbo

Latest:

Patient Engagement: A Key Element for Success in Value-Based Care

To support a value-based care model, healthcare organizations should focus on creating meaningful engagement throughout the patient's journey. This includes contacting patients at the right time through the right channel with relevant messages.


Rich Parker, M.D.

Latest:

The Impact of Vaccines on Long Covid

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.


Sabrina Serani

Latest:

CAR T-cell Therapy Shows 6-Year Durability in CLL Patients

A study suggests that a novel CAR T-cell therapy could be a curative treatment for some patients with chronic lymphocytic leukemia, with 25% of responders still in remission after 6 years.


Joshua Fitch

Latest:

Spending on Children’s Mental Health Conditions Increases, Study Finds

In 2021, pediatric mental health conditions were associated with $31 billion in child spending and $59 billion in household spending, which made up 46.6% of all pediatric medical spending that year.


Jerry Gross

Latest:

Shifting to an Endemic: How Tech Will Enable Greater Access to Affordable Healthcare

There are three key facets that must be considered in order to meet the demands of an endemic - the ongoing acceptance of a baseline of COVID-19 infection rates that will be maintained for the foreseeable future.


Mohammed S. Ahmed

Latest:

The Economic Impact of ADPKD on Patients, Payers

While physical and mental effects of Autosomal Dominant Polycystic Kidney Disease are top of mind for those personally impacted, as well as for nephrologists, the financial implications associated with this condition are often overlooked despite the fact that research has confirmed the economic burden of the disease increases over time for both the patient and the healthcare system.


Kaitlyn Bader

Latest:

SkinCure Oncology Secures Patent for Innovative Image-Guided Technology in Nonmelanoma Skin Cancer Treatment

SkinCure Oncology has not yet submitted its data to the FDA for marketing clearance, however once cleared, the new devices will use hybrid laser-generated confocal and photoacoustic imaging in a single fused volumetric image.


Jennifer Brigitte Green, MD

Latest:

Fixed-Ratio Combinations for Type 2 Diabetes

Dr Jennifer Brigitte Green considers the patient selection for fixed-ratio combinations of basal insulin and GLP-1 receptor agonists among patients with type 2 diabetes and provides insight around Medicare patient access to insulin and injectable medications.


Gary Mangiofico, Ph.D.

Latest:

Innovation or illusion? Evaluating CVS's CostVantage strategy

While CVS argues that its CostVantage model will provide more transparency and clarity in the pricing of drugs, there is no accompanying statement that this will lower drug prices.


Tim Webb

Latest:

Reinventing the Healthcare Workplace: Futurizing the Operating Model for Human Capital Management

Many leaders in healthcare would agree the healthcare sector has been operating in crisis mode for more than two straight years.


Quinn Dufurrena, D.D.S., J.D.

Latest:

Artificial Intelligence and Dental Claims Review: A More Predictable Consumer Experience

Artificial Intelligence in dentistry and dental benefits will lead to a shared understanding between consumers, dentists and insurers.



Eric Bacon

Latest:

3 Ways to Simplify Tech for Physicians

Some telemedicine software is so complex that it can lead to repetitive, mundane processes that are prone to frustration and mistakes.



Jon Wasson

Latest:

Where Are We Really With Interoperability?

New interoperability rules could require significant changes for healthcare organizations, but everyone will benefit from these improvements.


Mary Tolan

Latest:

Countless Americans Have Lost Employer Coverage. What Can Be Done?

In the four months between February and May, roughly 5.4 American workers lost their coverage.


Mark Menton

Latest:

Health Plan Executives Like Transparency Benefits, but Say Compliance is Complex

Another component of the government’s Transparency in Coverage mandate and No Surprises Act legislation for health insurance plans will go into effect on January 1, 2023 for price transparency.


David Hutton

Latest:

New Federal Rule Overhauls Health Insurers' Prior Authorization Processes

The rule comes as health insurers have increasingly been criticized for onerous and time-consuming prior authorization procedures that physicians say unfairly delay or deny the medical treatment that their patients need.


Robert Calandra

Latest:

Association Found Between MAFLD and Patients With Chronic HBV-related HCC

A retrospective study found that chronic hepatitis B-related hepatocellular carcinoma (HCC) patients with metabolic-associated fatty liver disease (MAFLD) had better outcomes than patients who did not have MAFLD.


Mark Simon, MD

Latest:

Policymakers Must Take Action to Ensure Maternal Health Extends Beyond the Labor and Delivery Room

If we look for the silver linings among lessons learned in 2020, the brightest positive outcome may be a better coordinated and more robust investment in public health. Yet as we continue to fight COVID-19 in the U.S., it’s important not to lose sight of another incredibly important battle we face on the public health front: maternal health.


Cara Obradovitz, B.S., M.P.H

Latest:

Staying Ahead of Employee Burn-out

Workplace stress is an inevitable part of business, but when stress gets out of hand, it’s bad for business and the people who do the work.


Paul Ceverha

Latest:

7 Actions Every Health System CFO Needs to Consider

Health systems are struggling as a result of the reduced activity of elective procedures, the loss of health coverage for many employees, and the resultant drop in billings. According to this article, there are seven approaches recommended for immediate consideration to increase revenues and stanch losses.

© 2024 MJH Life Sciences

All rights reserved.